Generation of ROS by CAY10598 leads to inactivation of STAT3 signaling and induction of apoptosis in human colon cancer HCT116 cells

References

• Srinivasan BD, Kulkarni PS. Inhibitors of the arachidonic acid cascade in the management of ocular inflammation. Prog Clin Biol Res 1989;312:229–349.
   PubMedGoogle Scholar
• Breyer RM, Bagdassarian CK, Myers SA, Breyer MD. Prostanoid receptors: subtypes and signaling. Annu Rev Pharmacol Toxicol 2001;41:661–690.
   PubMed Web of Science ®Google Scholar
• Regan JW. EP2 and EP4 prostanoid receptor signaling. Life Sci 2003;74:143–153.
   PubMed Web of Science ®Google Scholar
• Fujino H, Regan JW. Prostanoid receptors and phosphatidylinositol 3-kinase: a pathway to cancer? Trends Pharmacol Sci 2003;24:335–340.
   PubMed Web of Science ®Google Scholar
• Wang D, Dubois RN. Eicosanoids and cancer. Nat Rev Cancer 2010;10:181–193.
   PubMed Web of Science ®Google Scholar
• Wang D, Dubois RN. The role of COX-2 in intestinal inflammation and colorectal cancer. Oncogene 2010;29:781–788.
   PubMed Web of Science ®Google Scholar
• Lalier L, Cartron PF, Olivier C, Loge C, Bougras G, Robert JM, et al. Prostaglandins antagonistically control Bax activation during apoptosis. Cell Death Differ 2011; 18:528–537.
   Google Scholar
• Lalier L, Pedelaborde F, Braud C, Menanteau J, Vallette FM, Olivier C. Increase in intracellular PGE2 induces apoptosis in Bax-expressing colon cancer cell. BMC Cancer 2011; 11:153.
   PubMed Web of Science ®Google Scholar
• Okuyama T, Ishihara S, Sato H, Rumi MA, Kawashima K, Miyaoka Y, et al. Activation of prostaglandin E2-receptor EP2 and EP4 pathways induces growth inhibition in human gastric carcinoma cell lines. J Lab Clin Med 2002;140:92–102.
   PubMed Web of Science ®Google Scholar
• Planchon P, Veber N, Magnien V, Prevost G, Starzec AB, Israel L. Evidence for separate mechanisms of antiproliferative action of indomethacin and prostaglandin on MCF-7 breast cancer cells. Life Sci 1995;57:1233–1240.
   PubMed Web of Science ®Google Scholar
• Chell SD, Witherden IR, Dobson RR, Moorghen M, Herman AA, Qualtrough D, et al. Increased EP4 receptor expression in colorectal cancer progression promotes cell growth and anchorage independence. Cancer Res 2006;66:3106–3113.
   PubMed Web of Science ®Google Scholar
• Sheng H, Shao J, Washington MK, DuBois RN. Prostaglandin E2 increases growth and motility of colorectal carcinoma cells. J Biol Chem 2001;276:18075–18081.
   PubMed Web of Science ®Google Scholar
• Pozzi A, Yan X, Macias-Perez I, Wei S, Hata AN, Breyer RM, et al. Colon carcinoma cell growth is associated with prostaglandin E2/EP4 receptor-evoked ERK activation. J Biol Chem 2004;279:29797–29804.
   PubMed Web of Science ®Google Scholar
• Mutoh M, Watanabe K, Kitamura T, Shoji Y, Takahashi M, Kawamori T, et al. Involvement of prostaglandin E receptor subtype EP4 in colon carcinogenesis. Cancer Res 2002;62:28–32.
   PubMed Web of Science ®Google Scholar
• Cherukuri DP, Chen XB, Goulet AC, Young RN, Han Y, Heimark RL, et al. The EP4 receptor antagonist, L-161,982, blocks prostaglandin E2-induced signal transduction and cell proliferation in HCA-7 colon cancer cells. Exp Cell Res 2007;313:2969–2979.
   PubMed Web of Science ®Google Scholar
• Doherty GA, Byrne SM, Molloy ES, Malhotra V, Austin SC, Kay EW, et al. Proneoplastic effects of PGE2 mediated by EP4 receptor in colorectal cancer. BMC Cancer 2009;9:207.
   PubMed Web of Science ®Google Scholar
• Yamane H, Sugimoto Y, Tanaka S, Ichikawa A. Prostaglandin E2 receptors, EP2 and EP4, differentially modulate TNF-alpha and IL-6 production induced by lipopolysaccharide in mouse peritoneal neutrophils. Biochem Biophys Res Commun 2000;278:224–228.
   PubMed Web of Science ®Google Scholar
• Huang SK, White ES, Wettlaufer SH, Grifka H, Hogaboam CM, Thannickal VJ, et al. Prostaglandin E2 induces fibroblast apoptosis by modulating multiple survival pathways. FASEB J 2009;23:4317–4326.
   PubMed Web of Science ®Google Scholar
• Mori A, Ito S, Morioka M, Aso H, Kondo M, Sokabe M, Hasegawa Y. Effects of specific prostanoid EP receptor agonists on cell proliferation and intracellular Ca2+ concentrations in human airway smooth muscle cells. Eur J Pharmacol 2011;659:72–78.
   PubMed Web of Science ®Google Scholar
• Sastre B, Fernandez-Nieto M, Lopez E, Gamez C, Aguado E, Quirce S, et al. PGE(2) decreases muscle cell proliferation in patients with non-asthmatic eosinophilic bronchitis. Prostaglandins Other Lipid Mediat 2011;95:11–18.
   PubMed Web of Science ®Google Scholar
• Billot X, Chateauneuf A, Chauret N, Denis D, Greig G, Mathieu MC, et al. Discovery of a potent and selective agonist of the prostaglandin EP4 receptor. Bioorg Med Chem Lett 2003;13:1129–1132.
   PubMed Web of Science ®Google Scholar
• Shoji Y, Takahashi M, Kitamura T, Watanabe K, Kawamori T, Maruyama T, et al. Downregulation of prostaglandin E receptor subtype EP3 during colon cancer development. Gut 2004;53:1151–1158.
   PubMed Web of Science ®Google Scholar
• Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993;74:609–619.
   PubMed Web of Science ®Google Scholar
• Altieri DC. Survivin, versatile modulation of cell division and apoptosis in cancer. Oncogene 2003;22:8581–8589.
   PubMed Web of Science ®Google Scholar
• Rufini A, Melino G. Cell death pathology: the war against cancer. Biochem Biophys Res Commun 2011;414:445–450.
   PubMed Web of Science ®Google Scholar
• Janicke RU, Ng P, Sprengart ML, Porter AG. Caspase-3 is required for alpha-fodrin cleavage but dispensable for cleavage of other death substrates in apoptosis. J Biol Chem 1998;273:15540–15545.
   PubMed Web of Science ®Google Scholar
• Kadowaki H, Nishitoh H, Urano F, Sadamitsu C, Matsuzawa A, Takeda K, et al. Amyloid beta induces neuronal cell death through ROS-mediated ASK1 activation. Cell Death Differ 2005;12:19–24.
   PubMed Web of Science ®Google Scholar
• Rundhaug JE, Simper MS, Surh I, Fischer SM. The role of the EP receptors for prostaglandin E2 in skin and skin cancer. Cancer Metastasis Rev 2011;30:465–480.
   PubMed Web of Science ®Google Scholar
• Sheng H, Shao J, Morrow JD, Beauchamp RD, DuBois RN. Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells. Cancer Res 1998;58: 362–366.
   PubMed Web of Science ®Google Scholar
• Prijatelj M, Celhar T, Mlinaric-Rascan I. Prostaglandin EP4 receptor enhances BCR-induced apoptosis of immature B cells. Prostaglandins Other Lipid Mediat 2011;95:19–26.
   PubMed Web of Science ®Google Scholar
• Miyashita T, Reed JC. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 1995; 80:293–299.
   PubMed Web of Science ®Google Scholar
• Miyashita T, Krajewski S, Krajewska M, Wang HG, Lin HK, Liebermann DA, et al. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 1994;9:1799–1805.
   PubMed Web of Science ®Google Scholar
• Marubayashi S, Koppikar P, Taldone T, Abdel-Wahab O, West N, Bhagwat N, et al. HSP90 is a therapeutic target in JAK2-dependent myeloproliferative neoplasms in mice and humans. J Clin Invest 2010;120:3578–3593.
   PubMed Web of Science ®Google Scholar
• Herreros-Villanueva M, Garcia-Giron C, Er TK. No evidence for JAK2 V617F mutation in colorectal cancer. Br J Biomed Sci 2010;67:220–222.
   PubMed Web of Science ®Google Scholar
• Corvinus FM, Orth C, Moriggl R, Tsareva SA, Wagner S, Pfitzner EB, et al. Persistent STAT3 activation in colon cancer is associated with enhanced cell proliferation and tumor growth. Neoplasia 2005;7:545–555.
   PubMed Web of Science ®Google Scholar
• Lin Q, Lai R, Chirieac LR, Li C, Thomazy VA, Grammatikakis I, et al. Constitutive activation of JAK3/STAT3 in colon carcinoma tumors and cell lines: inhibition of JAK3/STAT3 signaling induces apoptosis and cell cycle arrest of colon carcinoma cells. Am J Pathol 2005;167:969–980.
   PubMed Web of Science ®Google Scholar
• Trachootham D, Lu W, Ogasawara MA, Nilsa RD, Huang P. Redox regulation of cell survival. Antioxid Redox Signal 2008;10:1343–1374.
   PubMed Web of Science ®Google Scholar
• Qi Z, Yin F, Lu L, Shen L, Qi S, Lan L, et al. Baicalein reduces lipopolysaccharide-induced inflammation via suppressing JAK/STATs activation and ROS production. Inflamm Res 2013;62:845–855.
   PubMed Web of Science ®Google Scholar
• Dixit D, Sharma V, Ghosh S, Koul N, Mishra PK, Sen E. Manumycin inhibits STAT3, telomerase activity, and growth of glioma cells by elevating intracellular reactive oxygen species generation. Free Radic Biol Med 2009;47:364–374.
   PubMed Web of Science ®Google Scholar
• Liu Y, Wang L, Wu Y, Lv C, Li X, Cao X, et al. Pterostilbene exerts antitumor activity against human osteosarcoma cells by inhibiting the JAK2/STAT3 signaling pathway. Toxicology 2013;304:120–131.
   PubMed Web of Science ®Google Scholar
• Sun X, Ai M, Wang Y, Shen S, Gu Y, Jin Y, et al. Selective induction of tumor cell apoptosis by a novel P450-mediated reactive oxygen species (ROS) inducer methyl 3-(4-nitrophenyl) propiolate. J Biol Chem 2013;288:8826–8837.
   PubMed Web of Science ®Google Scholar
• Lotem J, Peled-Kamar M, Groner Y, Sachs L. Cellular oxidative stress and the control of apoptosis by wild-type p53, cytotoxic compounds, and cytokines. Proc Natl Acad Sci USA 1996;93:9166–9171.
   PubMed Web of Science ®Google Scholar